Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anakinra in acute gout
NL-OMON40227Recruiting
- Sponsor
- Jan van Breemen Institute
- Start
- Mar 2017
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised trial in gout and acute gout flare comparing Anakinra continuation with Anakinra lead-in then placebo (2 arms). Primary endpoints: Reduction in pain after 72 hours, Prevention of recurrent gout attacks and 1 more. Started Mar 2017; status: recruiting.
02
Drugs
anakinra
03
Conditions
goutacute gout flare
Beyond the preview
Go deeper on NL-OMON40227.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON40227.